Abstract
The search for new pharmaceuticals for the treatment of hematologic patients have induced an increment on the number of studies with the aim of the production and purification of several biopharmaceuticals. Among them, the L-asparaginase (ASNase), a tetrameric enzyme used in chemoterapic sessions, have enlarged as one of the most promising for the Childhood Acute Lymphoblastic Leukemia Tr…